Table 2 DLEU2 expression associated with clinical pathological variables (logistic regression).

From: E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1

Characteristics

Total (N)

Odds Ratio (OR)

P value

T stage (T3&T4 vs. T2)

492

2.303 (1.591–3.353)

<0.001

N stage (N1 vs. N0)

426

2.909 (1.717–5.097)

<0.001

Primary therapy outcome (CR vs. PD&SD&PR)

438

0.532 (0.333–0.841)

0.007

Residual tumor (R1&R2 vs. R0)

468

1.321 (0.897–1.949)

0.159

PSA (ng/ml) (>=4 vs. <4)

442

3.071 (1.329–7.971)

0.013

Gleason score (9&10 vs. 6&7&8)

499

2.634 (1.761–3.983)

<0.001

Back to article page